History
  • No items yet
midpage
Ferring Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.
765 F.3d 205
| 3rd Cir. | 2014
Read the full case

Background

  • Ferring appeals district court denial of a preliminary injunction in a Lanham Act false advertising case against Watson.
  • Issue centers on whether Lanham Act claims carry a presumption of irreparable harm in preliminaries after eBay and Winter.
  • Watson's September 11, 2012 webcasts featured Dr. Silverberg's statements about Endometrin vs Crinone, including misstatements.
  • Allegations include mischaracterization of Black Box warning, faulty patient preference survey readings, and age-35+ efficacy claims.
  • Watson conceded certain statements were inaccurate and Dr. Silverberg pledged not to repeat them; some statements removed from later webcasts.
  • District Court found no ongoing misrepresentations proved irreparable harm and denied injunctive relief; Ferring appealed.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Lanham Act relief carries irreparable harm presumption Ferring seeks presumption based on Lanham Act false advertising history. eBay and Winter eliminate automatic presumption; require likelihood of irreparable harm. No presumption; irreparable harm must be shown likely.
Whether the district court correctly applied the irreparable harm standard Presumption would satisfy irreparable harm and justify injunction. Traditional equity applies; no presumption; must show likely irreparable harm. District court did not err; negligence of presumption and lack of likely irreparable harm shown.
Whether Beltsos declaration or other evidence creates irreparable harm Expert declaration shows potential irreparable impact on prescribing behavior and market perception. Declaration is speculative and insufficient; statements ceased and no ongoing harm shown. Beltsos declaration insufficient; no clear error; harm not demonstrated likely.

Key Cases Cited

  • eBay, Inc. v. MercExchange, L.L.C., 547 U.S. 388 (U.S. 2006) (presumption of irreparable harm rejected; traditional equity controls injunctive relief)
  • Winter v. Natural Resources Defense Council, Inc., 555 U.S. 7 (U.S. 2008) (injunctions require likelihood of irreparable harm; not mere possibility)
  • Kos Pharmaceutical, Inc. v. Andrx Corp., 369 F.3d 700 (3d Cir. 2004) (presumption for trademark infringement irreparable harm prior to eBay)
  • Opticians Ass’n of Am. v. Indep. Opticians of Am., 920 F.2d 187 (3d Cir. 1990) (per se injury for trademark infringement irreparably harms reputation)
  • McNeilab, Inc. v. American Home Prods. Corp., 848 F.2d 34 (2d Cir. 1988) (presumption of irreparable harm from false or misleading advertising)
  • Salinger v. Colting, 607 F.3d 68 (2d Cir. 2010) (eBay abrogates presumption in copyright; case-by-case equitable analysis)
  • Herb Reed Enters., LLC v. Fla. Entm’t Mgmt., Inc., 736 F.3d 1239 (9th Cir. 2013) (eBay applies to trademark injunctions; no automatic irreparable harm presumption)
  • Brookfield Communications v. West Coast Entm’t Corp., 174 F.3d 1036 (9th Cir. 1999) (illustrative of irreparable injury concepts in injunctions)
  • Monsanto Co. v. Geertson Seed Farms, 561 U.S. 139 (2010) (NEPA injunction standard aligned with traditional four-factor test)
Read the full case

Case Details

Case Name: Ferring Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.
Court Name: Court of Appeals for the Third Circuit
Date Published: Aug 26, 2014
Citation: 765 F.3d 205
Docket Number: 13-2290
Court Abbreviation: 3rd Cir.